Walvax’s modular workshop for SARS-CoV-2 mRNA Vaccine, the first modular mRNA workshop in China, has been delivered
Media
Sep 7, 2021
Walvax
On September 1, 2021, Walvax’s modular workshop for SARS-CoV-2 mRNA Vaccine, was officially delivered. It is an advanced process combining modular buildings with conventionally built facilities, which allows for tighter construction and can accelerate the industrialization schedule of SARS-CoV-2 mRNA Vaccine. Construction of modular buildings can occur simultaneously with the site and foundation work, allowing projects to be completed in a shorter period.
Related Links
May 21, 2022
Walvax Shipped the First Batch of 13-valent Pneumococcal Polysaccharide Conjugate Vaccine to the Kingdom of Morocco
Learn More
Oct 21, 2022
Walvax’s Management Member Elected to DCVMN Board
Learn More
Jun 3, 2020
HPV vaccine manufacturers commit to provide enough supply to immunise at least 84 million girls in Gavi countries
Learn More